PrimeRFP SCOUT · IDV / contract family

HHSN261201500003IIDV family

IDIQ HHSN261201500003I - 51 task orders is a federal IDV / contract family. SCOUT maps 51 distinctive task orders, with $104.0M obligated on the IDV rollup.

Nih Nci
Awarding office
Through Aug 29, 2029
Period
$104.0M
IDV obligated
51
Task orders

Watch this IDV family

One email. No account. We ping you when orders or incumbents under this IDV move.

Score my firm on this vehicle family — $90

Family facts

IDV
Parent PIIDHHSN261201500003I
AgencyNih Nci
Awarding officeNih Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Period endAug 29, 2029
IDV obligated$104.0M
Child awards51

Places of performance

States

MD

Distinctive task orders

12
75N91018F00073 — PDX PANELS FROM COMMON TUMORS
Leidos Biomedical Research, Inc. · $67.9M · PoP Sep 25, 2027
75N91018F00071 — HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23
Leidos Biomedical Research, Inc. · $67.0M · PoP Aug 31, 2027
75N91018F00059 — EBOLA VIRUS AND OTHER INFECTIOUS DISEASES
Leidos Biomedical Research, Inc. · $64.9M · PoP Sep 21, 2028
HHSN26100030 — RESEARCH, DEVELOPMENT, MANUFACTURE OF CLINICAL MATERIALS, AND CLINICAL TESTING OF VACCINES TO PROTECT AGAINST ZIKA VIRUS
Leidos Biomedical Research, Inc. · $63.7M · PoP Sep 21, 2021
75N91018F00079 — HHSN261201500003I; HHSN26100079; 400.001.0079.0001; NCI OD-FREDERICK; ROYALTY; B539 PHASE 2 REFURBISHMENT; 9/24/2018-9/…
Leidos Biomedical Research, Inc. · $58.1M · PoP Aug 25, 2023
75N91018F00077 — CELL-BASED IMMUNOTHERAPY PRODUCTS
Leidos Biomedical Research, Inc. · $53.5M · PoP Aug 29, 2029
HHSN26100033 — EBOLA VIRUS AND OTHER EMERGING AND RE-EMERGING INFECTIOUS DISEASES
Leidos Biomedical Research, Inc. · $44.4M · PoP Sep 25, 2021
HHSN26100043 — EBOLA VIRUS AND OTHER EMERGING & RE-EMERGING INFECTIOUS DISEASES
Leidos Biomedical Research, Inc. · $43.1M · PoP Sep 28, 2022
HHSN26100054 — A NATIONAL CLINICAL LABORATORY NETWORK FOR NCI PRECISION ONCOLOGY
Leidos Biomedical Research, Inc. · $38.5M · PoP Sep 20, 2022
HHSN26100042 — BIOBANK (MOONSHOT)
Leidos Biomedical Research, Inc. · $27.7M · PoP Sep 30, 2025
HHSN26100019 — RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
Leidos Biomedical Research, Inc. · $27.5M · PoP Sep 18, 2021
75N91018F00067 — ADVANCE VACCINE PLATFORMS FOR UNIVERSAL INFLUENZA VACCINE
Leidos Biomedical Research, Inc. · $27.1M · PoP Sep 29, 2023

Seen enough? Run one full capture cycle on HHSN261201500003I — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record family rollup + SCOUT analysis; personalized scoring in SCOUT.
primerfp.com/intel/contract/HHSN261201500003I